Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study

Inal, A.Isikdogan, A.Kos, T.Algin, E.Gumus, M.Dikilitas, M.Elkiran, E. T.2024-04-242024-04-2420110732-183X1527-7755https://doi.org/10.1200/jco.2011.29.15_suppl.e14534https://hdl.handle.net/11468/18277[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter studyGemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter studyConference Object2915WOS:00020888030358810.1200/jco.2011.29.15_suppl.e14534Q1